Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes.

Migita K, Koga T, Torigoshi T, Motokawa S, Maeda Y, Jiuchi Y, Izumi Y, Miyashita T, Nakamura M, Komori A, Ishibashi H.

Clin Exp Immunol. 2010 Nov;162(2):244-50. doi: 10.1111/j.1365-2249.2010.04242.x. Epub 2010 Sep 14.

2.

Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.

Liu FL, Chen CH, Chu SJ, Chen JH, Lai JH, Sytwu HK, Chang DM.

Rheumatology (Oxford). 2007 Aug;46(8):1266-73. Epub 2007 Jun 14.

PMID:
17569750
3.

Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes.

Migita K, Koga T, Torigoshi T, Maeda Y, Miyashita T, Izumi Y, Aiba Y, Komori A, Nakamura M, Motokawa S, Ishibashi H.

Rheumatology (Oxford). 2009 Jul;48(7):741-7. doi: 10.1093/rheumatology/kep089. Epub 2009 May 15.

PMID:
19447772
4.

Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products.

Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N.

J Rheumatol. 2008 May;35(5):752-6. Epub 2008 Mar 1.

PMID:
18322992
6.

Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes.

Koga T, Torigoshi T, Motokawa S, Miyashita T, Maeda Y, Nakamura M, Komori A, Aiba Y, Uemura T, Yatsuhashi H, Ishibashi H, Eguchi K, Migita K.

FEBS Lett. 2008 Mar 5;582(5):579-85. doi: 10.1016/j.febslet.2008.01.022. Epub 2008 Feb 1.

7.

Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synovium.

Migita K, Koga T, Komori A, Torigoshi T, Maeda Y, Izumi Y, Sato J, Jiuchi Y, Miyashita T, Yamasaki S, Kawakami A, Nakamura M, Motokawa S, Ishibashi H.

J Rheumatol. 2011 Nov;38(11):2309-17. doi: 10.3899/jrheum.101362. Epub 2011 Aug 15.

PMID:
21844139
8.

Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.

Harigai M, Hara M, Kawamoto M, Kawaguchi Y, Sugiura T, Tanaka M, Nakagawa M, Ichida H, Takagi K, Higami-Ohsako S, Shimada K, Kamatani N.

Arthritis Rheum. 2004 Jul;50(7):2167-77.

9.

Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways.

Kim HR, Cho ML, Kim KW, Juhn JY, Hwang SY, Yoon CH, Park SH, Lee SH, Kim HY.

Rheumatology (Oxford). 2007 Jan;46(1):57-64. Epub 2006 Jun 12. Erratum in: Rheumatology (Oxford). 2009 Apr;48(4):460. Kim, H-Y [corrected to Kim, Ho-Youn].

PMID:
16772307
10.

IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways.

Zhu L, Wu Y, Wei H, Xing X, Zhan N, Xiong H, Peng B.

Mol Immunol. 2011 Jan;48(4):647-56. doi: 10.1016/j.molimm.2010.11.008. Epub 2010 Dec 8.

PMID:
21145111
11.

Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes.

Satomura K, Torigoshi T, Koga T, Maeda Y, Izumi Y, Jiuchi Y, Miyashita T, Yamasaki S, Kawakami A, Aiba Y, Nakamura M, Komori A, Sato J, Ishibashi H, Motokawa S, Migita K.

Mod Rheumatol. 2013 Jan;23(1):28-35. doi: 10.1007/s10165-012-0630-0. Epub 2012 Mar 24.

PMID:
22447522
12.

Interleukin-18 induces serum amyloid A (SAA) protein production from rheumatoid synovial fibroblasts.

Tanaka F, Migita K, Kawabe Y, Aoyagi T, Ida H, Kawakami A, Eguchi K.

Life Sci. 2004 Feb 13;74(13):1671-9.

PMID:
14738910
13.

An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes.

Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, Ishibashi H, Eguchi K.

Rheumatology (Oxford). 2005 Apr;44(4):443-8. Epub 2005 Feb 3.

PMID:
15695308
14.

Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells.

Kumon Y, Suehiro T, Hashimoto K, Nakatani K, Sipe JD.

J Rheumatol. 1999 Apr;26(4):785-90.

PMID:
10229397
15.

Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.

Connolly M, Marrelli A, Blades M, McCormick J, Maderna P, Godson C, Mullan R, FitzGerald O, Bresnihan B, Pitzalis C, Veale DJ, Fearon U.

J Immunol. 2010 Jun 1;184(11):6427-37. doi: 10.4049/jimmunol.0902941. Epub 2010 Apr 30.

16.
17.

Synergism between tumor necrosis factor alpha and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes.

Goldberg M, Nadiv O, Luknar-Gabor N, Agar G, Beer Y, Katz Y.

Mol Immunol. 2009 May;46(8-9):1854-9. doi: 10.1016/j.molimm.2009.01.004. Epub 2009 Feb 6.

PMID:
19201028
19.

Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway.

Mullan RH, Bresnihan B, Golden-Mason L, Markham T, O'Hara R, FitzGerald O, Veale DJ, Fearon U.

Arthritis Rheum. 2006 Jan;54(1):105-14.

20.

The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes.

Kontny E, Szczepańska K, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, Maśliński W.

Arthritis Rheum. 2000 Oct;43(10):2169-77.

Supplemental Content

Support Center